Website | www.qiagen.com/us |
Research | OneLook Acronym Finder |
Serial Number | 90551592 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Randolph E. Digges, III |
Attorney Docket Number | GIL-50569 |
2021-02-28 | Application Filed |
2021-06-03 | Location: NEW APPLICATION PROCESSING |
2021-06-03 | Status: Live/Pending |
2021-06-03 | Transaction Date |
Owner: | Qiagen Sciences, LLC |
Address | 19300 Germantown Road Germantown DE 20874 |
Legal Entity Type | Limited Liability Company |
Legal Entity State | DE |
Application | MULTI | 2021-02-28 |
Drawing | JPEG | 2021-02-28 |
International Codes: | 1 |
U.S. Codes: | 001,005,006,010,026,046 |
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
International Codes: | 9 |
U.S. Codes: | 021,023,026,036,038 |
Type Code | Type |
---|---|
GS0011 | Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, diagnostic preparations except for human or veterinary medical purposes; non-medical reagents, enzymes and buffer solutions for scientific and/or medical research use; non-medical reagents, enzymes and buffer solutions for molecular biology applications; non-medical reagents, enzymes and buffer solutions for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; kits comprising chemicals for sample preparation, modification and manipulation of cells; kits comprising chemicals for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids of biological or biochemical sample material; kits comprising reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing |
GS0051 | Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposes, in particular diagnostics, for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; diagnostic chemical, biochemical and biotechnological preparations for medical and veterinary purposes, in particular reagents, enzymes and buffer solutions for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; diagnostic kits containing preparations for medical and veterinary diagnostic purposes, in particular for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-06-03 | 1 NWOS I:Incoming Correspondence |
TEAS VOLUNTARY AMENDMENT RECEIVED | 2021-06-04 | 2 PARI I:Incoming Correspondence |
ASSIGNED TO LIE | 2021-07-13 | 3 ALIE A:Allowance for Publication |
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | 2021-07-13 | 4 AMPX O:Outgoing Correspondence |
ASSIGNED TO EXAMINER | 2021-09-22 | 5 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2021-09-29 | 6 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2021-09-29 | 7 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2021-09-29 | 8 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-03-24 | 9 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-03-30 | 10 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-03-30 | 11 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-04-25 | 12 CNSA P: |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2022-05-11 | 13 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2022-05-31 | 14 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2022-05-31 | 15 NPUB E:E-Mail |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2022-07-28 | 16 NOAM E:E-Mail |
TEAS STATEMENT OF USE RECEIVED | 2022-09-23 | 17 EISU I:Incoming Correspondence |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2022-10-06 | 18 AITU A:Allowance for Publication |
USE AMENDMENT FILED | 2022-09-23 | 19 IUAF S: |
STATEMENT OF USE PROCESSING COMPLETE | 2022-10-07 | 20 SUPC I:Incoming Correspondence |
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2022-10-24 | 21 CNPR P: |
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2022-10-25 | 22 SUNA E:E-Mail |
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | 2022-10-28 | 23 ERRR O:Outgoing Correspondence |
ELECTRONIC RECORD REVIEW COMPLETE | 2023-05-10 | 24 FIXD O:Outgoing Correspondence |
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2023-05-11 | 25 SUNA E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2023-06-13 | 26 R.PR A:Allowance for Publication |
NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2023-06-13 | 27 NRCC E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.